194 related articles for article (PubMed ID: 10689610)
21. [Atypical antipsychotic drugs].
Kahn RS
Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1627-30. PubMed ID: 10972052
[TBL] [Abstract][Full Text] [Related]
22. [New antipsychotic drugs].
Weizer M; Levy A; Davidson M
Harefuah; 1997 Jul; 133(1-2):57-60. PubMed ID: 9332062
[No Abstract] [Full Text] [Related]
23. Impact of side-effects of atypical antipsychotics on non-compliance, relapse and cost.
Mortimer A; Williams P; Meddis D
J Int Med Res; 2003; 31(3):188-96. PubMed ID: 12870371
[TBL] [Abstract][Full Text] [Related]
24. [Atypical antipsychotics].
Naber D
Nervenarzt; 2000 May; 71(5):327-8. PubMed ID: 10846707
[No Abstract] [Full Text] [Related]
25. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
[TBL] [Abstract][Full Text] [Related]
26. Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
Sebastian CS; Glazer W; Buckley PF
Curr Med Chem; 2004 Feb; 11(3):329-42. PubMed ID: 14965235
[TBL] [Abstract][Full Text] [Related]
27. New antipsychotic medications: more than old wine and new bottles.
Schulz SC
Bull Menninger Clin; 2000; 64(1):60-75. PubMed ID: 10695160
[TBL] [Abstract][Full Text] [Related]
28. Atypical antipsychotic drugs and long-term outcome in schizophrenia.
Weiden P; Aquila R; Standard J
J Clin Psychiatry; 1996; 57 Suppl 11():53-60. PubMed ID: 8941171
[TBL] [Abstract][Full Text] [Related]
29. A model of anticholinergic activity of atypical antipsychotic medications.
Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
[TBL] [Abstract][Full Text] [Related]
30. One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis.
San L; Arranz B; Perez V; Safont G; Corripio I; Ramirez N; Dueñas R; Alvarez E
Psychiatry Res; 2012 Dec; 200(2-3):693-701. PubMed ID: 22954905
[TBL] [Abstract][Full Text] [Related]
31. [New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Möller HJ
Nervenarzt; 2000 May; 71(5):345-53. PubMed ID: 10846709
[TBL] [Abstract][Full Text] [Related]
32. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Keefe RS; Bilder RM; Davis SM; Harvey PD; Palmer BW; Gold JM; Meltzer HY; Green MF; Capuano G; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Davis CE; Hsiao JK; Lieberman JA; ;
Arch Gen Psychiatry; 2007 Jun; 64(6):633-47. PubMed ID: 17548746
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological approaches to the management of schizophrenia.
Lambert TJ; Castle DJ
Med J Aust; 2003 May; 178(S9):S57-61. PubMed ID: 12720524
[TBL] [Abstract][Full Text] [Related]
34. Clozapine: a comparison with other novel antipsychotics.
Fleischhacker WW
J Clin Psychiatry; 1999; 60 Suppl 12():30-4. PubMed ID: 10372608
[TBL] [Abstract][Full Text] [Related]
35. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Geddes J; Freemantle N; Harrison P; Bebbington P
BMJ; 2000 Dec; 321(7273):1371-6. PubMed ID: 11099280
[TBL] [Abstract][Full Text] [Related]
36. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
Lublin H; Haug HJ; Koponen H; Sigmundsson T; Kolb SA
World J Biol Psychiatry; 2009; 10(4 Pt 3):710-8. PubMed ID: 18803070
[TBL] [Abstract][Full Text] [Related]
37. Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.
Revicki DA
Curr Opin Investig Drugs; 2001 Jan; 2(1):110-7. PubMed ID: 11527002
[TBL] [Abstract][Full Text] [Related]
38. Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.
Raggi MA; Mandrioli R; Sabbioni C; Pucci V
Curr Med Chem; 2004 Feb; 11(3):279-96. PubMed ID: 14965232
[TBL] [Abstract][Full Text] [Related]
39. Emerging roles for novel antipsychotic medications in the treatment of schizophrenia.
Andersson C; Chakos M; Mailman R; Lieberman J
Psychiatr Clin North Am; 1998 Mar; 21(1):151-79. PubMed ID: 9551495
[TBL] [Abstract][Full Text] [Related]
40. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
